Development of research on cancer stem cells

doi:10.3877/cma.j.issn.2095-5820.2018.02.003

Abstract

Abstract:

At present, more and more evidences show that tumor stem cells (CSCs) play an important role in the occurrence and development of tumor. The CSCs theory is now widely accepted, and provides novel insights into the interpretation of tumor initiation, aggressive growth, recurrence, and metastasis, as well as the development of new strategies for cancer treatment. With the further study of CSCs biology, it will provide help for the diagnosis and treatment of tumor. This review will focus on the progress of theory and model of CSCs, introduce the origin and classification of CSCs.

Key words: Cancer stem cells, Origin, Classification, Cell fusion

Xiaoyong Zhan, Qingyi Zhu. Development of research on cancer stem cells[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2018, 06(02): 74-79.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcsysgldzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5820.2018.02.003

https://zhlcsysgldzzz.cma-cmc.com.cn/EN/Y2018/V06/I02/74

Figures/Tables 5

References 43

25	Chen L, Shen R, Ye Y, et al. Precancerous stem cells have the potential for both benign and malignant diffierentiation[J]. PLos One, 2007,2(3):e293.
26	Yamamoto Y, Wang X, Bertrand D, et al. Mutational spectrum of Barrett′s stem cells suggests paths to initiation of a precancerous lesion[J]. Nat Commun, 2016,7:10380.
27	Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis[J]. Gastroenterology, 2008,135(4):1079-1099.
28	Bae KM, Su Z, Frye C, et al. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells[J]. J Urol, 2010,183(5):2045-2053.
29	Fidler IJ. The pathogenesis of cancer metastasis: the′seed and soil′ hypothesis revisited[J]. Nat Rev Cancer, 2003,3(6):453.
30	Hermann P C, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer[J]. Cell Stem Cell, 2007,1(3):313-323.
31	Lu C, Xu F, Gu J, et al. Clinical and biological significance of stem-like CD133(＋)CXCR4(＋) cells in esophageal squamous cell carcinoma[J]. J Thorac Cardiovasc Surg, 2015,150(2):386-395.
32	Cioffi M, D′Alterio C, Camerlingo R, et al. Identification of a distinct population of CD133(＋)CXCR4(＋) cancer stem cells in ovarian cancer[J]. Sci Rep, 2015,5:10357.
33	Bertolini G, D′Amico L, Moro M, et al. Microenvironment-modulated metastatic CD133＋/CXCR4＋/EpCAM- lung cancer-initiating cells sustain tumor dissemination and correlate with poor prognosis[J]. Cancer Res, 2015,75(17):3636.
34	Yang ZF, Ho DW, Ng MN, et al. Significance of CD90＋cancer stem cells in human liver cancer[J]. Cancer Cell, 2008,13(2):153-166.
35	Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 2008,133(4):704-715.
36	Ansieau S. EMT in breast cancer stem cell generation[J]. Cancer Lett, 2013,338(1): 63-68.
37	Todaro M, Perez AM, Scopelliti A, et al. IL-4-mediated drug resistance in colon cancer stem cells[J]. Cell Cycle, 2008,7(3):309.
38	Paschall AV, Yang D, Lu C, et al. CD133＋CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype[J]. Oncotarget, 2016,7(48):78698-78712.
39	Ojha R, Bhattacharyya S, Singh SK. Autophagy in cancer stem cells: A potential link between chemoresistance, recurrence, and metastasis[J]. Biores Open Access, 2015,4(1): 97-108.
40	Yang HZ, Ma Y, Zhou Y, et al. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment[J]. Cancer Lett, 2015,361(1):128-136.
41	Xu ZY, Tang JN, Xie HX, et al. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells[J]. Int J Biol Sci, 2015,11(3):284-294.
42	Mouw KW, D′Andrea AD. Crosstalk between the nucleotide excision repair and Fanconi anemia/BRCA pathways[J]. Dna Repair, 2014,19:130-134.
1	La Porta C. Cancer stem cells: lessons from melanoma[J]. Stem Cell Rev, 2009,5(1): 61-65.
2	Ding L, Raphael BJ, Chen F, et al. Advances for studying clonal evolution in cancer[J]. Cancer Lett, 2013,340(2):212-219.
3	O′Connor ML, Xiang D, Shigdar S, et al. Cancer stem cells: A contentious hypothesis now moving forward[J]. Cancer Lett, 2014, 344(2):180-187.
4	Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001,414(6859):105.
5	Liu S, Ginestier C, Ou SJ, et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks[J]. Cancer Res, 2011,71(2):614-624.
6	Xu G, Shen J, Yang XO, et al. Cancer stem cells: the ′heartbeat′ of gastric cancer[J]. J Gastroenterol, 2013,48(7):781-797.
7	Gauck D, Keil S, Niggemann B, et al. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells[J]. BMC Cancer, 2017,17(1):515.
8	Wang R, Chen S, Li C, et al. Fusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor-initiating cells[J]. BMC Cancer, 2016,16(1): 1-9.
9	Luo F, Liu T, Wang J, et al. Bone marrow mesenchymal stem cells participate in prostate carcinogenesis and promote growth of prostate cancer by cell fusion in vivo[J]. Oncotarget, 2016,7(21):30924-30934.
10	Fujiwara T, Bandi M, Nitta M, et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells[J]. Nature, 2005,437(7061):1043-1047.
11	Vant Veer LJ, Weigelt B. Road map to metastasis[J]. Nat Med, 2003,9(8):999-1000.
12	Pawelek JM, Chakraborty AK. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis[J]. Nat Rev Cancer, 2008,8(5):377-386.
13	Lu X, Kang Y. Organotropism of breast cancer metastasis[J]. J Mammary Gland Biol Neoplasia, 2007,12(2-3):153-162.
14	Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism[J]. Int J Exp Pathol, 2000,81(5):291-304.
15	Sondag GR, Mbimba TS, Moussa FM, et al. Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling[J]. Exp Mol Med, 2016,48(9):e257.
16	Horsley V, Jansen KM, Mills ST, et al. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth[J]. Cell, 2003,113(4):483-494.
17	Guan GF, Tang XX, Zhang DJ, et al. Constitutive secretion of Interleukin-4 dictates CD133＋ side population cells to resist drug treatment and cell death[J]. J Buon, 2015,20(5):1350.
18	He X, Li B, Yang S, et al. Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation[J]. BMC Cancer, 2015,15(1):24.
19	Mohr M, Zaenker KS, Dittmar T. Fusion in cancer: An explanatory model for aneuploidy, metastasis formation, and drug resistance[J]. Methods Mol Biol, 2015,1313:21.
20	Lindström A, Midtbö K, Arnesson LG, et al. Fusion between M2-macrophages and cancer cells results in a subpopulation of radioresistant cells with enhanced DNA-repair capacity[J]. Oncotarget, 2017,8(31):51370.
21	Fan H, Lu S. Fusion of human bone hemopoietic stem cell with esophageal carcinoma cells didn′t generate esophageal cancer stem cell[J]. Neoplasma, 2014,61(5):540-545.
22	Liu HG, Chong C, Han Y, et al. Cancer stem cell subsets and their relationships[J]. J Transl Med, 2011,9(1):50.
23	Tongtawee T, Wattanawongdon W, Simawaranon T, et al. Expression of Cancer Stem Cell Marker CD44 and Its Polymorphisms in Patients with Chronic Gastritis, Precancerous Gastric Lesion, and Gastric Cancer: A Cross-Sectional Multicenter Study in Thailand[J]. Biomed Res Int, 2017,2017:e4384823.
24	Mukherjee A, Ellis IO, Rakha EA. Molecular pathology of precancerous lesions of the breast[M]. New York: Springer, 2015.
43	Dou C, Fang C, Zhao Y, et al. BC-02 eradicates liver cancer stem cells by upregulating the ROS-dependent DNA damage[J]. Int J Oncol, 2017, 51(6):1775-1784.

[1]	Shuyi Lyu, Yan Zhang, Meiwu Zhang, Xiaoxiang Fan, Libo Gao, Fei Li. Role of an automated artificial intelligence detection system in diagnosis of small breast masses by physicians with varying levels of experience [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(09): 983-989.
[2]	Zhenxia Li, Xiaowen Zheng, Fang Ji, Lunguo Xia, Rongjing Chen, Qingling You, Bing Fang. Research on the application of flipped classroom mode based on Bloom′s taxonomy of educational objectives in orthodontic teaching [J]. Chinese Journal of Stomatological Research(Electronic Edition), 2023, 17(02): 133-139.
[3]	Huasheng Liu, Hongxia Wang, Zheng Ma, Lei Wang. Surgical treatment of hyperfunction of complex type A3 parathyroid adenoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 705-706.
[4]	Kaimei Gan, Jian Huang. Research progress in the effect of lung cancer stem cells on EGFR-TKI drug resistance [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(01): 36-44.
[5]	Jianqi Wang, Zhengliang Chen, Yu Liu, Xingxin Yu, Zhida Geng, Hongchi Jiang, Yingjian Liang. Analysis of anatomical variation of hepatic vessels based on three-dimensional CT reconstruction in160 patients [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 427-433.
[6]	Renfei Zhu, Qiuqi Feng, Feng Xiao, Zhi Chen, Fan Yang. Application of Clavien-Dindo classification and comprehensive complication index in safety evaluation of hepatectomy for elderly patients with hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 312-316.
[7]	Jialu Fu, Jingwei Zhang, Zhechuan Jin, Dong Zhang, Zhimin Geng. Rationality of clinical classification of gallbladder carcinoma and its relationship with clinical prognosis: a single-center analysis of 486 cases [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(02): 173-178.
[8]	Dong Zhang, Zhimin Geng, Zhiwei Quan. Current research and advance of clinical classification of gallbladder cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(02): 147-152.
[9]	Jiansheng Hu, Zuolin Zhou, Linmei Sun, Tenghui Ma. Clinical outcomes of chronic radiation rectal injury with different diagnostic types: a retrospective analysis of 85 cases [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 466-472.
[10]	Gang Hu, Junguang Liu, Wenlong Qiu, Shiwen Mei, Jichuan Quan, Meng Zhuang, Jianqiang Tang, Xishan Wang. Risk factors for Clavien-Dindo Grade Ⅱ and above complications after laparoscopic intersphincteric resection for rectal cancer and its effect on prognosis [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(04): 296-302.
[11]	Xiaopei Xu, Junlin Zhou, Yang Liu, Dong Wang, Hanzhou Wang, Shuo Diao, Yuling Gao, Tianchao Lu. Intra- and interobserver reliability of Bartonícek classification of subscapular glenoid fractures [J]. Chinese Journal of Shoulder and Elbow(Electronic Edition), 2023, 11(01): 45-52.
[12]	Huan Li, Yushu Tang, Xuan Wang, Xisheng Xie. Progress in research on diagnosis and treatment of pulmonary infection in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2022, 11(05): 285-289.
[13]	Jingke Li, Yanchun Zhang, Jiayi Wu, Xiuyu Ren. Deep learning for diabetic retinopathy screening, classification and management [J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2023, 13(04): 241-246.
[14]	Xiaobin Zhang, Yingdi Liu, Juan Wang, Guohui Sun, Lisen Zhong, Zhandi He, Enqiang Linghu. Experience for the management of isolated gastric varices [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(03): 167-172.
[15]	Zhiming Zhou, Wei Jiang, Zexue Wang, Bo Qu, Lei Liang, Min Zhang. Internal fixation of costal arch fracture [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2023, 10(02): 63-69.

Please choose a citation manager

Content to export